{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:26:16Z","timestamp":1782699976546,"version":"3.54.5"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>The World Health Organization recommends annual treatment of entire trachoma-endemic communities, although children typically have a higher load, longer duration, and greater likelihood of infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>Forty-eight communities in Matameye, Niger, were randomized to annual oral azithromycin treatment of the entire community or biannual treatment of children aged 0\u201312 years only. Both children and adults were monitored for ocular chlamydial infection by polymerase chain reaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>The prevalence of childhood infection was reduced in the annually treated arm from 21.2% (95% confidence interval [CI], 15.2%\u201328.0%) at baseline to 5.8% (95% CI, 3.2%\u20139.0%) at 36 months (P &amp;lt; .001) and in the biannual arm from 20.2% (95% CI, 15.5%\u201325.3%) to 3.8% (95% CI, 2.2%\u20136.0%; P &amp;lt; .001). Adult infection in the annual arm was reduced from 1.7% (95% CI, .9%\u20132.7%) to 0.3% (95% CI, .0%\u2013.7%) and in the biannual arm from 1.2% (95% CI, .5%\u20132.2%) to 0.0% (95% CI, .0%\u2013.7%; P = .005). The effect of biannual treatment of children compared with annual treatment of the entire community in both children (95% CI, \u2013.04% to .02%) and adults (95% CI, .9%\u20132.7%) excluded the prespecified noninferiority threshold of 6% (P = .003 and P &amp;lt; .001, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>Periodic distribution of antibiotics to children in trachoma-endemic communities reduces chlamydial infection in both children and untreated adults, suggesting a form of herd protection. Biannual treatment of children was comparable to (specifically, noninferior to) annual treatment of the entire community, and may offer lower antibiotic use and other logistical advantages.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration.<\/jats:title>\n                  <jats:p>NCT00792922.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciw810","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T12:05:45Z","timestamp":1481198745000},"page":"743-750","source":"Crossref","is-referenced-by-count":20,"title":["A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children"],"prefix":"10.1093","volume":"64","author":[{"given":"Abdou","family":"Amza","sequence":"first","affiliation":[{"name":"Programme FSS\/Universit\u00e9 Abdou Moumouni de Niamey, Programme National de Sant\u00e9 Oculaire 1 , Niamey , ;","place":["Niger"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Kadri","sequence":"additional","affiliation":[{"name":"Programme FSS\/Universit\u00e9 Abdou Moumouni de Niamey, Programme National de Sant\u00e9 Oculaire 1 , Niamey , ;","place":["Niger"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beido","family":"Nassirou","sequence":"additional","affiliation":[{"name":"Programme FSS\/Universit\u00e9 Abdou Moumouni de Niamey, Programme National de Sant\u00e9 Oculaire 1 , Niamey , ;","place":["Niger"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Y.","family":"Cotter","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Stoller","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Zhou","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine 3 , London , ;","place":["United Kingdom"]},{"name":"Departments of 3 , London , ;","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Mabey","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine 3 , London , ;","place":["United Kingdom"]},{"name":"Departments of 3 , London , ;","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Porco","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"},{"name":"Ophthalmology 4 and"},{"name":"Epidemiology and Biostatistics, University of California 5 , San Francisco ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Keenan","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"},{"name":"Ophthalmology 4 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Gaynor","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"},{"name":"Ophthalmology 4 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"West","sequence":"additional","affiliation":[{"name":"Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University 6 , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[{"name":"F.I. Proctor Foundation, University of California 2 , San Francisco ;"},{"name":"Ophthalmology 4 and"},{"name":"Epidemiology and Biostatistics, University of California 5 , San Francisco ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"key":"2024111411402691700_CIT0001","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(13)62182-0","article-title":"Trachoma","volume":"384","author":"Taylor","year":"2014","journal-title":"Lancet"},{"key":"2024111411402691700_CIT0002","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1086\/374743","article-title":"Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?","volume":"187","author":"Bird","year":"2003","journal-title":"J Infect Dis"},{"key":"2024111411402691700_CIT0003","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/8451","article-title":"Global elimination of trachoma: how frequently should we administer mass chemotherapy?","volume":"5","author":"Lietman","year":"1999","journal-title":"Nat Med"},{"key":"2024111411402691700_CIT0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.aje.a117420","article-title":"Herd immunity: basic concept and relevance to public health immunization practices. 1971","volume":"141","author":"Fox","year":"1995","journal-title":"Am J Epidemiol"},{"key":"2024111411402691700_CIT0005","first-page":"279","article-title":"Core group sand R0s for subgroup sin heterogeneous SIS and SI models","volume-title":"Epidemic models: their structure and relation to data","author":"Jacquez","year":"1995"},{"key":"2024111411402691700_CIT0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e318074e01b","article-title":"The real challenge: can we discover why trachoma is disappearing before it\u2019s gone?","volume":"47","author":"House","year":"2007","journal-title":"Int Ophthalmol Clin"},{"key":"2024111411402691700_CIT0007","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/INF.0b013e31824155c9","article-title":"Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children","volume":"31","author":"Coles","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2024111411402691700_CIT0008","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3201\/eid1507.081563","article-title":"Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma","volume":"15","author":"Hong","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2024111411402691700_CIT0009","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/AAC.49.11.4804-4806.2005","article-title":"Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis","volume":"49","author":"Solomon","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2024111411402691700_CIT0010","doi-asserted-by":"crossref","first-page":"e1000377","DOI":"10.1371\/journal.pmed.1000377","article-title":"Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial","volume":"7","author":"Skalet","year":"2010","journal-title":"PLoS Med"},{"key":"2024111411402691700_CIT0011","first-page":"201","article-title":"Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children","volume":"79","author":"Frick","year":"2001","journal-title":"Bull World Health Organ"},{"key":"2024111411402691700_CIT0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/09286586.2010.545500","article-title":"Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the partnership for rapid elimination of trachoma (PRET) in Tanzania and The Gambia","volume":"18","author":"Stare","year":"2011","journal-title":"Ophthalmic Epidemiol"},{"key":"2024111411402691700_CIT0013","doi-asserted-by":"crossref","first-page":"e2115","DOI":"10.1371\/journal.pntd.0002115","article-title":"Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET trial in The Gambia","volume":"7","author":"Harding-Esch","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2024111411402691700_CIT0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jamaophthalmol.2013.2356","article-title":"Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma? PRET Ziada trial results","volume":"131","author":"Yohannan","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"2024111411402691700_CIT0015","doi-asserted-by":"crossref","first-page":"e1586","DOI":"10.1371\/journal.pntd.0001586","article-title":"Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial","volume":"6","author":"Amza","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2024111411402691700_CIT0016","first-page":"477","article-title":"A simple system for the assessment of trachoma and its complications","volume":"65","author":"Thylefors","year":"1987","journal-title":"Bull World Health Organ"},{"key":"2024111411402691700_CIT0017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/09286586.2014.884600","article-title":"Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing","volume":"21","author":"Ray","year":"2014","journal-title":"Ophthalmic Epidemiol"},{"key":"2024111411402691700_CIT0018","volume-title":"Nonparametrics. Statistical methods based on ranks","author":"Lehman","year":"2006"},{"key":"2024111411402691700_CIT0019","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/526777","article-title":"Complete elimination is a difficult goal for trachoma programs in severely affected communities","volume":"46","author":"Gill","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024111411402691700_CIT0020","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ophtha.2009.04.041","article-title":"Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions","volume":"116","author":"Biebesheimer","year":"2009","journal-title":"Ophthalmology"},{"key":"2024111411402691700_CIT0021","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1086\/424747","article-title":"Mass antibiotic treatment and community protection in trachoma control programs","volume":"39","author":"Chidambaram","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2024111411402691700_CIT0022","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1167\/iovs.13-12701","article-title":"Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania","volume":"55","author":"Shekhawat","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024111411402691700_CIT0023","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMc0706263","article-title":"Two doses of azithromycin to eliminate trachoma in a Tanzanian community","volume":"358","author":"Solomon","year":"2008","journal-title":"N Engl J Med"},{"key":"2024111411402691700_CIT0024","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0950268899003076","article-title":"The duration of human ocular Chlamydia trachomatis infection is age dependent","volume":"123","author":"Bailey","year":"1999","journal-title":"Epidemiol Infect"},{"key":"2024111411402691700_CIT0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0140-6736(03)13909-8","article-title":"Strategies for control of trachoma: observational study with quantitative PCR","volume":"362","author":"Solomon","year":"2003","journal-title":"Lancet"},{"key":"2024111411402691700_CIT0026","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMoa040979","article-title":"Mass treatment with single-dose azithromycin for trachoma","volume":"351","author":"Solomon","year":"2004","journal-title":"N Engl J Med"},{"key":"2024111411402691700_CIT0027","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(05)61029-X","article-title":"Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study","volume":"365","author":"Burton","year":"2005","journal-title":"Lancet"},{"key":"2024111411402691700_CIT0028","first-page":"194","article-title":"Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal","volume":"79","author":"Holm","year":"2001","journal-title":"Bull World Health Organ"},{"key":"2024111411402691700_CIT0029","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(09)60323-8","article-title":"Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial","volume":"373","author":"House","year":"2009","journal-title":"Lancet"},{"key":"2024111411402691700_CIT0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.00519-13","article-title":"Comparison of the Abbott m2000 RealTime CT assay and the Cepheid GeneXpert CT\/NG assay to the Roche Amplicor CT assay for detection of Chlamydia trachomatis in ocular samples from Tanzania","volume":"51","author":"Dize","year":"2013","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/6\/743\/10834144\/ciw810.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/6\/743\/10834144\/ciw810.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:57:03Z","timestamp":1731585423000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/6\/743\/2670366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,12]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,12,12]]},"published-print":{"date-parts":[[2017,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw810","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,3,15]]},"published":{"date-parts":[[2016,12,12]]}}}